SCRUTINY GLOBAL
Direct access to verified B2B decision makers, clinical healthcare specialists, and national representative consumer panels across 70+ countries. Backed by our 26-step zero-bot data integrity gate architecture.
First-party recruited and continuously scrubbed respondent networks across specialized professional and consumer segments.
Corporate domain gated access to C-Suite, IT Decision Makers, CISOs, Procurement Directors, and Finance Controllers with confirmed signing authority.
NPI & GMC registry-verified oncologists, cardiologists, primary care GPs, and formulary hospital payors with 24-hour pharmacovigilance AE safety.
Census-balanced consumer panels profiled across 120+ demographic, psychographic, and purchasing variables for concept testing and tracking.
Synthetic bot traffic and click-farms are eliminated before final data delivery through 3 sequential, deterministic defense gates.
From initial questionnaire scripting through automated quota balancing to clean cryptographic delivery.
Feasibility desk calculates exact incidence rates ($IR\%$), sample sizes ($N$), and fieldwork timelines.
Least-fill routing algorithms prevent over-sampling while maintaining demographic and firmographic parity.
Data tables exported directly to SPSS, CSV, Parquet, or interactive client dashboards with provenance tokens.
Fieldwork capabilities spanning 70+ core sovereign research markets across North America, Latin America, Europe, Asia Pacific, and the Middle East.
Surveying Fortune 1000 CIOs and cloud architects across US, UK, Germany, and Japan with 100% corporate domain verification.
NPI-verified medical oncologists evaluating next-generation checkpoint inhibitor regimens under EphMRA and HIPAA protocols.
Continuous 12-wave longitudinal consumer tracking across 8 international markets with wave-over-wave conditioning locks.
Submit project specifications directly to our senior methodologists. You will receive guaranteed feasibility counts, incidence validation, and custom pricing within 90 minutes.
